@inproceedings{discovery1572791,
          series = {Lecture Notes in Computer Science},
       publisher = {Springer},
            year = {2018},
           title = {Automatic Brain Tumor Segmentation using Cascaded Anisotropic Convolutional Neural Networks},
         journal = {BRAINLESION: GLIOMA, MULTIPLE SCLEROSIS, STROKE AND TRAUMATIC BRAIN INJURIES, BRAINLES 2017},
          volume = {10670},
         address = {Cham, Switzerland},
            note = {This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.},
           pages = {178--190},
       booktitle = {BrainLes 2017: Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries},
          editor = {A Crimi and S Bakas and H Kuijf and B Menze and M Reyes},
        keywords = {Brain tumor, Convolutional neural network, Segmentation},
             url = {https://doi.org/10.1007/978-3-319-75238-9\%5f16},
            issn = {1611-3349},
        abstract = {A cascade of fully convolutional neural networks is proposed to segment multi-modal Magnetic Resonance (MR) images with brain tumor into background and three hierarchical regions: whole tumor, tumor core and enhancing tumor core. The cascade is designed to decompose the multi-class segmentation problem into a sequence of three binary segmentation problems according to the subregion hierarchy. The whole tumor is segmented in the first step and the bounding box of the result is used for the tumor core segmentation in the second step. The enhancing tumor core is then segmented based on the bounding box of the tumor core segmentation result. Our networks consist of multiple layers of anisotropic and dilated convolution filters, and they are combined with multi-view fusion to reduce false positives. Residual connections and multi-scale predictions are employed in these networks to boost the segmentation performance. Experiments with BraTS 2017 validation set show that the proposed method achieved average Dice scores of 0.7859, 0.9050, 0.8378 for enhancing tumor core, whole tumor and tumor core, respectively. The corresponding values for BraTS 2017 testing set were 0.7831, 0.8739, and 0.7748, respectively.},
          author = {Wang, G and Li, W and Ourselin, S and Vercauteren, T}
}